comparemela.com

Latest Breaking News On - Hariprasad venugopal - Page 1 : comparemela.com

Researchers discover nanobodies inhibit SARS-CoV-2 infection

Researchers discover nanobodies inhibit SARS-CoV-2 infection ANI | Updated: Apr 26, 2021 22:46 IST Melbourne [Australia], April 26 (ANI): In a groundbreaking discovery, Australian researchers have identified neutralising nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models. Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute. At a glance -Researchers have identified nanobodies that effectively blocked the SARS-CoV-2 virus from entering cells in pre-clinical models of COVID-19 infection. -Nanobodies - which are tiny immune proteins - could provide an alternative to conventional antibody treatments for COVID-19.

Researchers identify nanobodies that block COVID-19 infection

Researchers identify nanobodies that block COVID-19 infection Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models. The discovery paves the way for further investigations into nanobody-based treatments for COVID-19. Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute. At a glance Researchers have identified nanobodies that effectively blocked the SARS-CoV-2 virus from entering cells in pre-clinical models of COVID-19 infection. Nanobodies - which are tiny immune proteins - could provide an alternative to conventional antibody treatments for COVID-19.

Nanobodies inhibit SARS-CoV-2 infection

Date Time Nanobodies inhibit SARS-CoV-2 infection Australian researchers have identified neutralising nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models. The discovery paves the way for further investigations into nanobody-based treatments for COVID-19. Visualisation of SARS-CoV-2 virus with nanobodies (purple) attaching to the virus ‘spike’ protein. Image: Dr Drew Berry in collaboration with Associate Professor Wai-Hong Tham Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute. At a glance Researchers have identified nanobodies that effectively blocked the SARS-CoV-2 virus from entering cells in pre-clinical models of COVID-19 infection.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.